Page-2 of Topic: Remdesivir
Hetero’s injectable ‘Covifor’ gets DCGI approval for COVID-19 Treatment
For the treatment of COVID-19 positive cases, on 21st June 2020, Hyderabad based pharmaceutical company -Hetero Drugs has received approval from the Drug Controller General of India (a...
Remdesivir now a part of COVID-19 therapy in new health protocol
The Union Health Ministry has recently included Remdesivir as a part of investigational therapy and updated Clinical Management Protocol of COVID-19 patients. The ministry has also added loss...
WHO suspended Hydroxycloroquine trials
The World Health Organization recently suspended its trials on the efficacy of the drug Hydroxychloroquine in treating COVID-19. The HCQ trial is one of the four mega trials...
US to donate Ventilators to India
The United States recently announced that it will donate ventilators to India. The announcement is seen as a reciprocal gesture of India’s lift on the export ban of...
COVID-19: ICMR participates in Global Solidarity Trials of WHO
The Indian Council for Medical Research is to participate in Global Solidarity Trial of COVID-19 launched by the World Health Organization (WHO). About the trials The WHO has...
What is Corona Virus Copy Machine?
After COVID-19 virus invades a human cell, it begins to replicate or copy itself. In order to achieve this, the virus uses its enzyme called “copy machine”. With...
USFDA approves emergency use of an investigational vaccine, Remdesivir
The United States Food and Drug Regulatory body recently allowed emergency use of anti-viral investigational vaccine Remdesivir to treat COVID-19 patients. Highlights The USFDA has approved the vaccine...
